The Marshall Protocol Study Site > PROF. MARSHALL'S PERSPECTIVE > Prof. Marshall's Perspective > Immunostimulation in the Era of the Metagenome
|
|
The Marshall Protocol Study Site > PROF. MARSHALL'S PERSPECTIVE > Prof. Marshall's Perspective > Immunostimulation in the Era of the Metagenome |
|
| Moderated by: Prof Trevor Marshall | ||
| Author | Post | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prof Trevor Marshall Foundation Staff 
|
This morning Cellular and Molecular Immunology published our paper: "Immunostimulation in the Era of the Metagenome." http://www.nature.com/cmi/journal/vaop/ncurrent/abs/cmi201077a.html My sincere thanks to the many who helped Amy write this wonderful paper. Its particular significance is that it describes for the first time the phenomena of immunopathology, and describes clinical events which many physicians may regard as adverse events, showing that they were an integral component of the healing process. A full-text preprint is online at: http://autoimmunityresearch.org/preprints/Proal2010CellularMolecularImmunologyPreprint.pdf ...Trevor.. |
|||||||||
|
JohnMcC Member* 
|
Dr M The pre-print download is only 1 page - will the rest become available? Many Thanks John Worked after a few attempts - windows...grr Last edited on Mon Jan 31st, 2011 07:20 by JohnMcC |
|||||||||
|
terrylmcc Member 
|
GOOD WORK, AND CONGRATULATIONS TO ALL THAT CONTRIBUTED. JOHN, All 20 pages are available on this end. I would give the link another try. Best --Terry |
|||||||||
|
scooker48 Member*
|
This is a turning point for everyone at Autoimmunity Research Foundation and the MP. Keep up the good work. Sherry |
|||||||||
|
Deedee inactive member 
|
" Cases like A.C.’s strongly suggest that the sooner an immunostimulative treatment is started, the less immunopathology a patient may have to manage, and the quicker the potential recovery." This would be good info to reference on the MPKB, since from time to time someone will state he is and he will wait to wait to see if the disease will "go away." |
|||||||||
|
ChrisMavo Member 
|
Bravo!! Excellent paper!! I congratulate all of those who contributed to it. Let us hope that with the publication of this paper and the recent chapter in the book, that the Marshall Protocol will begin to become a mainstream treatment option for more people suffering chronic disease worldwide! |
|||||||||
|
scooker48 Member*
|
I finished reading the paper last night, and it is the most lucid explanation yet. I will be sending it out to friends... Sherry |
|||||||||
|
Pipistrelle inactive member 
|
Many thanks to everyone who worked so hard on this. It is so clear to read, I too will be sending it off to key people. Congratulations! Morag |
|||||||||
|
Ames Research Team 
|
Hi guys, For those of you that have commented, I'm so glad you like the paper! I'm happy that you think it's fairly accessible! I also appreciate your kind words about the book chapter for the JCVI textbook. It was nice to finally have a forum in which to really pull the Pathogenesis together. I hope everyone is herxing tolerably and take care! Amy |
|||||||||
|
Pipistrelle inactive member
|
Pity we don't have a thanks button, would have pressed it oh, several hundred times... thanks again for all the team's dedication and diligence. Morag |
|||||||||
|
Guss Wilkinson inactive member 
|
Fantastic paper guys. I just had a health check - my first since getting off the MP at the new year (after 7-years). I feel really good and my health check indicated that I am in good shape all round except for a couple of the blood test results. This paper explains the out of range values for kidney and liver functions, which suggest that I may be a little premature in stopping the MP. But it doesn't explain the elevated calcium results (which is at 3.00 mmol/L). This result has my GP really concerned as it could indicate malignancy. Any comments? Cheers Guss |
|||||||||
|
Prof Trevor Marshall Foundation Staff
|
Correlation of calcium with malignancy does not imply causation. You are correct, you did stop Olmesartan too soon, let it do its job, which includes a number of cancer-protective pathways. See, for example, the two I talk about here: http://www.youtube.com/watch?v=y8AfUg3aJVk Great to hear things are going well, Guss  ..Trevor.. |
|||||||||
|
k Member
|
Yep, definitely accessible Amy. |
|||||||||
|
wirion Member* 
|
Hi! I'm not sure whether this is the right place to ask for this, but I would like to show the published version of Amy's paper to my doctor (rather than the preprint). I know it shouldn't make a difference, but doctors are people and might take the published version more seriously. In any case, massive thanks to Amy and her coauthors for their fantastic work! François |
|||||||||
|
paulalbert Research Team 
|
Hi François, I feel the same way. The original seems to carry more weight. So, here it is for now: http://dl.dropbox.com/u/2014679/Proal2011MolecularClinicalFinal.pdf I will take it down in 24 hours or so. Any chance you would care to contribute to a French translation of the MP? This is a Google Translate version of this page, and we need a French speaker to clean up this rough automated translation. http://mpkb.org/home/translations/french Best, Paul |
|||||||||
|
Jigsaw Research Team 
|
Tahnks for a great paper. I am though a bit confused by the rather non-sequitor mention of epidermal growth factor receptor (EGFR) a the bottom of p8, followed by discussion of eGFR (estimated Glomerular Filtration Rate) and kidney function. |
|||||||||
|
Prof Trevor Marshall Foundation Staff
|
Sigh... Typos do slip through now and then... |
|||||||||
|
paulalbert Research Team
|
Yes, typos do "slip through now and then" but this was not a typo. This change was introduced by editorial for the pre-print. Then when we were reviewing this suggested change, we told editorial, "This change would be bad. Please use 'estimated glomerular filtration rate'." I don't understand why they would ask for us to review their changes if they're just going to ignore them. Paul |
|||||||||
|
Prof Trevor Marshall Foundation Staff
|
paulalbert wrote: I don't understand why they would ask for us to review their changes if they're just going to ignore them. I never argue with an editor They don't listen, and then they don't publish you again Through 20 years of editors at Byte.com I never found one which deviated from that methodology 'Time and motion' drives everything in the print business |
|||||||||
|
wirion Member*
|
Hi Paul, and thanks for the paper. Yes I'll give editing the French translation of the MP a shot. I should mention that despite my name I'm not a native French speaker. I had a brief look at the Google translated document and did find some errors. On Sunday I'll go on holiday for 3 weeks, but tomorrow I'll have some time to look at it in more depth. |
|||||||||